|
|
||||||||
Departments of 1 Physiology, 2 Internal Medicine and Immunology, and 3 Human Anatomy and Cell Science, University of Manitoba, Winnipeg R3E 3J7; and 4 Institute of Cardiovascular Sciences, St. Boniface Hospital Research Centre, Winnipeg, Manitoba, Canada R2H 2A6
Fibroblast growth factor-2 (FGF-2) is
cardioprotective when added exogenously, stimulates cardiac myocyte
proliferation, and is a mediator of tissue repair after injury.
Furthermore, transgenic (TG) mice overexpressing FGF-2 in cardiac
muscle demonstrate increased resistance to injury in an isolated heart
model of ischemia-reperfusion. We investigated how increasing
the endogenous FGF-2 levels in the heart affects the extent of
myocardial damage induced by isoproterenol in vivo. Histopathological
evaluation of hearts after intraperitoneal injection of isoproterenol
yielded significantly higher scores for myocardial damage in FGF-2 TG
lines compared with non-TG mice. After 1 day, FGF-2 TG mouse hearts
displayed more cellular infiltration correlating with increased tissue
damage. Immunostaining of non-TG and FGF-2 TG mouse hearts showed the
presence of leukocytes in the infiltrate, including T cells expressing
FGF receptor-1. Treatment of mice with T cell suppressors cyclosporin A
and anti-CD3
significantly decreased the level of myocardial injury
observed after isoproterenol and equalized the histopathology scores in
FGF-2 TG and non-TG hearts. These data demonstrate a direct T cell
involvement in the response to isoproterenol-induced injury in vivo.
Moreover, the findings indicate that the exacerbation of myocardial
damage in FGF-2 TG mice was dependent on T cell infiltration,
implicating FGF-2 in the inflammatory response seen in cardiac tissue
after injury in vivo.
myocardium; lymphocytes
This article has been cited by other articles:
![]() |
Y. Mizukami, K. Ono, C.-K. Du, T. Aki, N. Hatano, Y. Okamoto, Y. Ikeda, H. Ito, K. Hamano, and S. Morimoto Identification and physiological activity of survival factor released from cardiomyocytes during ischaemia and reperfusion Cardiovasc Res, September 1, 2008; 79(4): 589 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Rosenberg Interview with Dr. Andrew Issekutz regarding Pivotal Advance: Endothelial growth factors VEGF and bFGF differentially modulate monocyte and neutrophil recruitment to inflammation J. Leukoc. Biol., August 1, 2006; 80(2): 245 - 246. [Full Text] [PDF] |
||||
![]() |
K. A. Detillieux, F. Sheikh, E. Kardami, and P. A. Cattini Biological activities of fibroblast growth factor-2 in the adult myocardium Cardiovasc Res, January 1, 2003; 57(1): 8 - 19. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |